Utah Innovation Fund’s Post

Synbiobeta last week was awesome! Maybe one of the best conferences I have attended. Not only were there talks by great scientists like Paul Stamets 🍄 and Craig Venter (picture below), but I reconnected with fermentation people at Genencor/DuPont/IFF, and BASF. Furthermore, I was able to meet many other innovators/service providers/investors during the conference. I feel very blessed to have spent two decades in this field. Although summarizing what I saw in bullet points is difficult, here it goes: • The conference felt very commercial in comparison to when it started, and not in a bad way. This is an indication that biotech has evolved over the past decade from the abstract or medical to the very practical. • The ecosystem is vibrant. There are many start-ups, service providers, innovators and investors from different countries all under one roof. To be candid, I was gladly surprised to see a couple of the Fortune 500 companies I worked for in the conference. • AI 🧠 is impacting everything including biotech. Although there are a lot of initiatives only time will tell which ones are the ones that will pan out commercially. Huge shout-out to Ginkgo Bioworks, Inc. and SynBioBeta for providing our start-up with a grant so that we could attend. I won't tag names, but building a start-up, just like raising a child 👶, takes a village. #synbio #synbiobeta #biotech #fermentation

🌟 Exciting News from ATAGENIX 🌟 We're thrilled to unveil an exclusive video that takes you behind the scenes at ATAGENIX, a trailblazer in the biotechnology sector. Discover how our cutting-edge innovations and dedicated team are setting new benchmarks in healthcare solutions. 🔬 From groundbreaking research to transformative health technologies, get an insider’s look at how ATAGENIX is shaping the future of biotech and making a profound impact on lives around the globe. 📈 Learn about our journey, our mission, and the visionary technologies that stand at the forefront of our efforts to redefine what's possible in the biotech industry. 💡 Whether you're a professional in the field, a potential partner, or simply passionate about the next wave of biotech innovations, this video is for you! #ATAGENIX #Biotechnology 

This is an exciting time for growth and innovation in the biotech industry. If you are one of my contacts from the biotech community (or even if you are not), I'd like to personally invite you to Seattle's Biotech Network event on September 6th. It promises to be well worth your time because you are investing in building your professional network. See Details and link in the comment. #biotechnologyindustry #innovation #scienceandtechnology #lifescience #STEM

🗞️ It's time for the final #BiopôleNews round-up of the year! Here's a glimpse of what's been happening in our community over the past few weeks: 🤝 BD is joining Biopôle's Corporate Partnership Programme. A leading #medtech stakeholder, BD becomes Biopôle’s ninth corporate partner. 👋 We welcome Hycann Health SA as it launches medical cannabis distribution operations at Biopôle. 🏥 Unisanté has developed and trialled a new digital clinical decision-making tool, aimed at combating the over-prescription of antibiotics to children, with promising results. 👩🔬The recent approval of Aspivix's Carevix product for commercialisation in the US and Europe paves the way for the company to expand worldwide, improving women's gynaecological experiences. 💡SIB Swiss Institute of Bioinformatics, in collaboration with Lunaphore, has secured Innosuisse funding to develop innovative AI-based tools. 📈 genknowme and Resistell have been selected for phase 1 of Innosuisse's Scale-up Coaching programme – these Biopôle-based #startups will work on their strategy with a team of coaches to unlock their full growth potential. 👉 Read more about the amazing #LifeSciences work happening at Biopôle here: https://lnkd.in/eC6stPac

Last week, we were joined by Enveda Biosciences' Director of Operations, Joel Basken, and Nicolette Surges, their Lab Manager, to talk about the importance of a supportive and integrated tech stack for a growing lab. 💻 🌱 🔬 If you missed our webinar, watch the recording to hear real-life stories and get actionable tips on: - How to recognize triggers telling you it’s time to level up your tech solution. - How to avoid costly mistakes when your early-stage lab starts to grow. - How to build a mature ecosystem of tech tools that will support your lab's growth rather than hinder it. The on-demand webinar is available now: https://lnkd.in/e4dMGeWH #ZAGENOwebinar #techstack #labsupplies #lifescience #biotech #techtips

Catch Noblespace in Philly this week! CEO Howard Kozloff will guide a panel discussion around leasing flexibility, demand, and deals at the Bisnow International Life Sciences & Biotech Conference. Science and R&D activity is strong but funding to expand into bigger, newer labs is at a trickle, leaving pent-up demand among promising growth-stage companies and some serious head-scratching moments. Let’s hear how creative collaboration can get deals unstuck and over the finish line. #biotech #realestate

🚀 Exciting news! 🚀 Thrilled to announce that I'll be sharing insights on a panel discussion at BioFIT in Marseille next week! 🌐 Join me as we delve into the dynamic world of biotech spin-outs and explore the fascinating journey "From lab to start-up." 🔬 Panel Topic: "From Lab to Start-Up: Let’s hear about successful spin-out journeys" 🌱 Navigating the spin-off roadmap: join me and fellow life science professionals as we unravel the strategies and lessons learned from successful biotech spin-outs. We'll be tackling crucial questions: 🔍 License or Launch: How do you decide whether to license a technology to an existing company or take the plunge and set up a spin-off? Let's explore the key considerations and decision-making factors. 🔄 The spin-off blueprint: What are the critical steps and challenges in spinning out a company based on academic research? Get ready for a deep dive into the intricacies of transforming groundbreaking research into a thriving start-up. Looking forward to a dynamic discussion! See you in Marseille! 👋🔬✨ #BioFIT #biotech #lifesciences #innovation #startupsuccess #spinoff

🤔 What are the new frontiers in #TechBio? How do we see the intersection of biology and tech evolving?   This Wednesday was the launch of a new HTBC TechBio chapter led by Leigh Brody, AlbionVC life sciences investor. TechBio Club is a breakfast session that welcomes founders, operators, and investors for a quarterly deepdive on the state of the TechBio ecosystem.   Thank you to our stellar first panel: Javier Nunez-Vicandi, Sofinnova Partners, Paul Ashley, Johnson & Johnson, Ian McKay, Innovate UK Leigh Brody, AlbionVC (Moderator) Key take-aways from the discussion include: 🖖 There remains a gap in the investment landscape - techbio companies require investors with understanding both tech and bio 👨💻 The growth of techbio has been in part thanks to AI within the life science sector, but challenges around genetic data, regulatory hurdles, ethical considerations and incorporation into clinical practice are just a few of the hurdles 🌍 It's expected that there will be a streamlining of aids targeting 'low-hanging' problems soon, highlighting the dynamic nature of the field and the ongoing quest for innovation Many thanks to HSBC Innovation Banking for hosting this quarter's session at their offices and supporting this event. If you are operating in the space and would like to join the next session, register your interest here: https://lnkd.in/e_bW72gw #healthcare #techbio #digitalhealth #deeptech #lifesciences #ai #drugdiscovery #vc #founders #operators #experts #investors #venturecapital #community

“Should I stay or should I go?” You might recognize those words as lyrics from The Clash; however, they also pertain to the decision to stay in academia or join the world of pharma and biotech. What happens when one leaves the sector and role they’ve known to carve out an entirely new career and skills in another? This is precisely what Adam Schwartz, Ramin Farhood and Benit M. discuss in this episode of the Emerging Biotech Leader—a follow up to Episode 21 featuring Victoria Niklas, Chief Medical Officer at Oak Hill Bio. 🎧 Tune in to Episode 22 of The Emerging Biotech Leader & dive deeper on the topics below: https://lnkd.in/drM2nnC5 ◽ The benefits of going from academia to industry  ◽ How 'guarded optimism' comes into play in developing new therapies ◽ Why the knowledge and expertise brought over from academia is essential for the success of the industry ◽ Reflections on CMOs and their delicate balance between science and business considerations #biotech #academiatobiotech #careershift

It's Friday, so you know what that means... time for the weekly iBIO NewsBrief Quiz! 🧬🔬 Biotech Brilliance: Weekly Knowledge Challenge Attention biotech enthusiasts! Test your grasp of recent developments in the life sciences. How well do you know the latest news? Let's find out! One lucky (and knowledgeable) quiz taker will win a special prize for answering all questions correctly. But we're not going to make it easy... good luck! Ready to put your expertise to the test? Dive in and see how you measure up in this fast-paced weekly roundup of biotech breakthroughs. May the odds be in your favor! 🍀 Take the quiz: https://bit.ly/4ey8B7y #BiotechQuiz #LifeSciences #FridayChallenge